ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Water → 1-(4-((3-(4-(1H-Pyrazol-1-yl)benzyl)-4-chloro-2-methoxyquinolin-6-yl)(hydroxy)(phenyl)methyl)piperidin-1-yl)ethanone

HRID 928854
印刷

反応式

HRID 928854 の反応式
[Li]CCCC.[N:6]1([C:11]2[CH:31]=[CH:30][C:14]([CH2:15][C:16]3[C:17]([O:28][CH3:29])=[N:18][C:19]4[C:24]([C:25]=3[Cl:26])=[CH:23][C:22](Br)=[CH:21][CH:20]=4)=[CH:13][CH:12]=2)[CH:10]=[CH:9][CH:8]=[N:7]1.[C:32]([CH:40]1[CH2:45][CH2:44][N:43]([C:46](=[O:48])[CH3:47])[CH2:42][CH2:41]1)(=[O:39])[C:33]1[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=1.O>C1COCC1>[N:6]1([C:11]2[CH:31]=[CH:30][C:14]([CH2:15][C:16]3[C:17]([O:28][CH3:29])=[N:18][C:19]4[C:24]([C:25]=3[Cl:26])=[CH:23][C:22]([C:32]([OH:39])([C:33]3[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=3)[CH:40]3[CH2:45][CH2:44][N:43]([C:46](=[O:48])[CH3:47])[CH2:42][CH2:41]3)=[CH:21][CH:20]=4)=[CH:13][CH:12]=2)[CH:10]=[CH:9][CH:8]=[N:7]1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 962WaterHCID 27407141-Acetyl-4-benzoylpiperidine2 回HCID 867155963-(4-(1H-Pyrazol-1-yl)benzyl)-6-bromo-4-chloro-2-methoxyquinoline2 回HCID 178418339Butyllithium

生成物 1

HCID 742214651-(4-((3-(4-(1H-Pyrazol-1-yl)benzyl)-4-chloro-2-methoxyquinolin-6-yl)(hydroxy)(phenyl)methyl)piperidin-1-yl)ethanone

試薬・触媒・溶媒

1
HCID 8028Tetrahydrofuran溶媒3 回

反応条件

温度
-78 °C

実験手順

A solution of n-BuLi (2.5 M in hexanes, 0.208 mL, 0.333 mmol) was added dropwise by syringe to a solution of 3-(4-(1H-pyrazol-1-yl)benzyl)-6-bromo-4-chloro-2-methoxyquinoline (150 mg, 0.350 mmol, Intermediate 16) in dry THF (3.5 mL) at −78° C. After 3 minutes, a solution of 1-(4-benzoylpiperidin-1-yl)ethanone (80.9 mg, 0.350 mmol, Intermediate 52) in dry THF (3.5 mL) was added dropwise. An additional 0.5 mL of dry THF was used to quantitate the transfer. The reaction mixture was stirred for 5 minutes at −78° C., and the flask was placed into an ice-water bath. After 30 minutes, water (5 mL) was added. The biphasic mixture was warmed to room temperature then partitioned between water (25 mL) and ethyl acetate (40 mL). The layers were separated. The organic layer was dried with sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified by flash column chromatography (silica gel, 50% ethyl acetate-hexanes initially, grading to 100% ethyl acetate) and then by reverse phase HPLC [5% acetonitrile-water (containing 0.05% TFA v/v) initially, grading to 5% water (containing 0.05% TFA v/v)-acetonitrile] to provide the title compound as a white solid. 1H NMR (500 MHz, CDCl3) δ ppm 8.31-8.25 (m, 1H), 7.85 (d, J=2.4 Hz, 1H), 7.80-7.72 (m, 1H), 7.71-7.61 (m, 2H), 7.59-7.47 (m, 4H), 7.39-7.29 (m, 4H), 7.27-7.19 (m, 1H), 6.46-6.40 (m, 1H), 4.76-4.62 (m, 1H), 4.31 (s, 2H), 4.05 (s, 3H), 3.83 (t, J=16.3 Hz, 1H), 3.17-3.00 (m, 1H), 2.83-2.71 (m, 1H), 2.66-2.53 (m, 1H), 2.06 (s, 3H), 1.75-1.29 (m, 4H). MS (ESI): mass calcd. C34H33ClN4O3, 580.2; m/z found, 581.2 [M+H]+. This racemate was separated by chiral HPLC (Chiralpak AD column, 250 gram, 50 mm×21 cm, ethanol eluent, 80 mL/minute, 240 nm wavelength) to give two enantiomers. The first eluting enantiomer was Example 83B: 1H NMR (500 MHz, CDCl3) δ ppm 8.29 (dd, J=8.1, 2.1 Hz, 1H), 7.87-7.82 (m, 1H), 7.79-7.72 (m, 1H), 7.71-7.61 (m, 2H), 7.59-7.48 (m, 4H), 7.38-7.29 (m, 4H), 7.26-7.18 (m, 1H), 6.46-6.39 (m, 1H), 4.75-4.61 (m, 1H), 4.31 (s, 2H), 4.05 (s, 3H), 3.81 (t, J=16.2 Hz, 1H), 3.14-3.00 (m, 1H), 2.82-2.69 (m, 1H), 2.64-2.51 (m, 1H), 2.03 (s, 3H), 1.76-1.20 (m, 4H); MS (ESI): mass calcd. C34H33ClN4O3, 580.2; m/z found, 581.2 [M+H]+ and the second eluting enantiomer was Example 83C: 1H NMR (500 MHz, CDCl3) δ ppm 8.29 (dd, J=8.1, 2.1 Hz, 1H), 7.85 (d, J=2.3 Hz, 1H), 7.79-7.72 (m, 1H), 7.71-7.61 (m, 2H), 7.59-7.48 (m, 4H), 7.38-7.29 (m, 4H), 7.26-7.18 (m, 1H), 6.45-6.40 (m, 1H), 4.75-4.60 (m, 1H), 4.31 (s, 2H), 4.05 (s, 3H), 3.89-3.75 (m, 1H), 3.15-2.98 (m, 1H), 2.82-2.70 (m, 1H), 2.64-2.49 (m, 1H), 2.04 (s, 3H), 1.75-1.28 (m, 4H); MS (ESI): mass calcd. C34H33ClN4O3, 580.2; m/z found, 581.2 [M+H]+.

後処理

  1. customthe flask was placed into an ice-water bath
  2. waitAfter 30 minutes
  3. temperatureThe biphasic mixture was warmed to room temperature
  4. customthen partitioned between water (25 mL) and ethyl acetate (40 mL)
  5. customThe layers were separated
  6. dry with materialThe organic layer was dried with sodium sulfate
  7. filtrationThe dried solution was filtered
  8. concentrationthe filtrate was concentrated
  9. customThe residue was purified by flash column chromatography (silica gel, 50% ethyl acetate-hexanes initially
  10. additioncontaining 0.05% TFA v/v) initially,
  11. additioncontaining 0.05% TFA v/v)-acetonitrile]

出典と根拠

ORDレコード
ord-57aa5af7abae482d97ff10fbe6dc5f0d
出典データセット
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09290476B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート